James Andrea S. 4
4 · Oncocyte Corp · Filed Oct 4, 2024
Insider Transaction Report
Form 4
James Andrea S.
Chief Financial Officer
Transactions
- Purchase
Common Stock, no par value
2024-10-02$2.97/sh+33,670$100,000→ 33,670 total
Footnotes (1)
- [F1]Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of October 2, 2024, by and among the Issuer and the investors signatory thereto.